← FDA Drug Approvals (Drugs@FDA)

ZINBRYTA

BLA · Biologics License Application · Sponsor: BIOGEN · Approved 2016-05-27

Drug application

FDA Application #

BLA761029

Application type

Biologics License Application

Brand name

ZINBRYTA

Generic name

Daclizumab

Active ingredients

DACLIZUMAB

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

BIOGEN

First approval

2016-05-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown